Crohn's Disease and Colitis Trial, Recruiting NCT06693310 Sponsor: University of Chicago Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT06693310
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 75 who have given their consent and have been diagnosed with ulcerative colitis (a type of inflammatory bowel condition affecting the large intestine) for at least 3 years.
  • People whose ulcerative colitis is in "deep remission," meaning a colonoscopy performed within the last 12 months showed no signs of active inflammation in the tissue samples taken — or, if the most recent colonoscopy was within the last 3 years and showed the same result, a consistently normal stool test result (called a calprotectin test) may be accepted instead (confirm with trial site).
  • People who have been in full remission — with no symptoms, normal stool test results (calprotectin below 100), normal imaging, and no signs of inflammation on colonoscopy — since their last colonoscopy.

Who may not be able to join:

  • People who have any signs of active inflammation, whether through symptoms, ultrasound, blood or stool tests, or colonoscopy findings in any part of the large intestine.
  • People who have changed their ulcerative colitis treatment at any point after a colonoscopy confirmed their inflammation had settled.
  • People who have used corticosteroid medications (a type of anti-inflammatory drug) after a colonoscopy confirmed their inflammation had settled.
  • People who have a history of a liver condition called primary sclerosing cholangitis, or who have been found to have high-grade dysplasia (abnormal cells that could indicate a risk of cancer) that could not be seen clearly or was not removed.
  • People who are pregnant or actively trying to become pregnant.
  • People who would not be able to follow the required sample collection and monitoring schedule throughout the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: David T Rubin, MD, University of Chicago

Phone: 215-596-9715

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 November 2025
Est. completion
1 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of individuals with sustained biochemical remission; Number of individuals with sustained sonographic remission; Number of individuals with sustained clinical remission; Number of individuals with sustained endoscopic remission

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov